Prevalence of age-related macular degeneration (AMD) in comparable population-based studies
| Study name | Country | Age group (year) | Early AMD (%) | Late AMD (%) | Atrophic AMD (%) | Neovascular AMD (%) |
|---|---|---|---|---|---|---|
| Baltimore Eye Survey* | USA | 40–49 | 0.0 | 0.0 | 0.0 | |
| 1985–198817 | 50–59 | 0.5 | 0.2 | 0.4 | ||
| 60–69 | 0.7 | 0.7 | 0.0 | |||
| 70–79 | 2.9 | 1.8 | 1.6 | |||
| 80+ | 7.0 | 4.0 | 5.6 | |||
| Beaver Dam Eye Study | USA | 43–54 | 8.4 | 0.1 | ||
| 1988–199018 | 55–64 | 13.8 | 0.6 | |||
| 65–74 | 18.0 | 1.4 | ||||
| 75+ | 29.7 | 7.1 | ||||
| Blue Mountains Eye Study | Australia | 49–54 | 1.3 | 0.0 | ||
| 1992–199319 | 55–64 | 2.6 | 0.2 | |||
| 65–74 | 8.5 | 0.7 | ||||
| 75–84 | 15.5 | 5.4 | ||||
| 85+ | 28.0 | 18.5 | ||||
| Reykjavik Eye Study | Iceland | 50–59 | 8.9 | 0.3 | 0.3 | 0.0 |
| 199620 | 60–69 | 16.4 | 1.2 | 1.2 | 0.0 | |
| 70–79 | 27.5 | 5.8 | 5.3 | 0.5 | ||
| >80 | 37.1 | 30.8 | 25.0 | 9.8 | ||
| MESA* | USA | 45–54 | 1.8 | 0.0 | ||
| 2000–200221 | 55–64 | 2.8 | 0.1 | |||
| 65–74 | 5.5 | 0.3 | ||||
| 75–84 | 13.3 | 2.9 | ||||
| TILDA Study | ROI | 50–64 | 4.9 | 0.1 | 0.1 | 0.1 |
| 2009–2011 | 65–74 | 7.3 | 0.5 | 0.2 | 0.2 | |
| ≥75 | 11.0 | 2.2 | 1.3 | 1.0 |
*Data on only white participants. MESA, Multi-ethnic Study of Atherosclerosis; ROI, Republic of Ireland; TILDA, the Irish Longitudinal Study on Ageing.